HIV-1 vaccine development: progress and prospects (Q36718578)

15 August 2017

HIV-1 vaccine development: progress and prospects (English)

1 reference

15 August 2017

2

Dan H Barouch

1 reference

15 August 2017

Anna R Thorner

1

1 reference

15 August 2017

1 January 2007

1 reference

Current infectious disease reports

15 August 2017

1 reference

15 August 2017

9

1 reference

15 August 2017

1

1 reference

15 August 2017

71-75

1 reference

Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein

15 August 2017

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11908-007-0025-0

Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11908-007-0025-0

A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11908-007-0025-0

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

21 January 2018

1 reference

12 December 2020

Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines.

1 reference

12 December 2020

Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-ad5 immunity

1 reference

12 December 2020

Antibody neutralization and escape by HIV-1

1 reference

12 December 2020

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

1 reference

12 December 2020

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort

1 reference

12 December 2020

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

12 December 2020

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

1 reference

12 December 2020

A formalin-inactivated whole SIV vaccine confers protection in macaques

1 reference

12 December 2020

Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection

1 reference

12 December 2020

Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity

1 reference

12 December 2020

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

1 reference

12 December 2020

The Global HIV/AIDS Vaccine Enterprise: scientific strategic plan

1 reference

12 December 2020

HIV preferentially infects HIV-specific CD4+ T cells

1 reference

12 December 2020

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

12 December 2020

Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity

1 reference

12 December 2020

Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

1 reference

12 December 2020

Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef.

1 reference

12 December 2020

Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection

1 reference

12 December 2020

Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

1 reference

12 December 2020

Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV.

1 reference

12 December 2020

Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies.

1 reference

12 December 2020

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

1 reference

12 December 2020

Anti-cell antibody in macaques

1 reference

12 December 2020

Enhancement of DNA vaccine potency in rhesus macaques by electroporation

1 reference

12 December 2020

Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection

1 reference

12 December 2020

Replication-defective vector based on a chimpanzee adenovirus

1 reference

12 December 2020

Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level

1 reference

12 December 2020

Medicine. The need for a global HIV vaccine enterprise

1 reference

12 December 2020

Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector

1 reference

12 December 2020

The antigenic structure of the HIV gp120 envelope glycoprotein

1 reference

12 December 2020

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

1 reference

12 December 2020

Vaccination preserves CD4 memory T cells during acute simian immunodeficiency virus challenge

1 reference

12 December 2020

Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeys

1 reference

12 December 2020

Detection of acute infections during HIV testing in North Carolina.

1 reference

12 December 2020

Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques

1 reference

12 December 2020

Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors

1 reference

12 December 2020

Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells.

1 reference

12 December 2020

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

1 reference

12 December 2020

Structure of an unliganded simian immunodeficiency virus gp120 core

1 reference

12 December 2020

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

12 December 2020

Evaluation of HIV-1 Immunogen, an Immunologic Modifier, Administered to Patients Infected With HIV Having 300 to 549 × 10 6 /L CD4 Cell Counts A Randomized Controlled Trial

1 reference

12 December 2020

Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia

1 reference

12 December 2020

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

1 reference

12 December 2020

Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys

1 reference

12 December 2020

Quantifying the uncertainty in forecasts of anthropogenic climate change

1 reference

27 September 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/35036559

Identifiers

DOI

10.1007/S11908-007-0025-0

1 reference

15 August 2017

1 reference

PubMed ID

17254507